Low Centyl K 1.25 mg/573 mg modified-release tablets

国家: 爱尔兰

语言: 英文

来源: HPRA (Health Products Regulatory Authority)

有效成分:

Bendroflumethiazide; Potassium chloride

可用日期:

Leo Laboratories Limited

ATC代码:

C03AB; C03AB01

INN（国际名称）:

Bendroflumethiazide; Potassium chloride

剂量:

1.25/573 milligram(s)

药物剂型:

Modified-release tablet

处方类型:

Product subject to prescription which may be renewed (B)

治疗领域:

Thiazides and potassium in combination; bendroflumethiazide and potassium

授权状态:

Marketed

授权日期:

1997-11-14

资料单张

Page 1 of 7
PACKAGE LEAFLET: INFORMATION FOR THE USER
LOW CENTYL
® K 1.25 MG/573 MG MODIFIED-RELEASE TABLETS
bendroflumethiazide/potassium chloride
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT
CONTAINS IMPORTANT INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you only. Do not pass it on to
others. It
may harm them, even if their signs of illness are the same as yours.

If you get any side effects, talk to your doctor or pharmacist. This
includes any
possible side effects not listed in this leaflet. See section 4.

In this leaflet, Low Centyl
®
K modified-release tablets will be called Low
Centyl
K.
WHAT IS IN THIS LEAFLET
1.
What Low Centyl
®
K is
and what it is used for
2. What you need to know before you take Low Centyl
®
K
3. How to take Low Centyl
®
K
4. Possible side effects
5. How to store Low Centyl
®
K
6. Contents of the pack and other information
1.
WHAT LOW CENTYL
® K IS AND WHAT IT IS USED FOR
Low Centyl K contains two different types of active substances. One is
called
bendroflumethiazide, it is a diuretic (water tablet). The other active
substance is called
potassium chloride. It is a potassium supplement. The two medicines
work at the
same time in different ways.
Low Centyl K works by removing any excess water from your body. It
will make you
go to the toilet more. This means you will also lose potassium from
your body. The
potassium chloride in Low Centyl K is a supplement to replace some of
the potassium
you may lose.
Low Centyl K is used:
To treat high blood pressure (hypertension). Your doctor may also
decide to give you
other blood pressure lowering medicines as well as this medicine.
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE LOW CENTYL
® K
DO NOT TAKE LOW CENTYL K:

If
you
are
allergic
(hypersensitive)
to
bendroflumethiazide
or
potassium
chloride, or any of the other ingredients of this medicine (listed

产品特点

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Low Centyl K 1.25 mg/573 mg modified-release tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 1.25mg of bendroflumethiazide and 573mg of
potassium chloride.
For the full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Modified-release tablet.
Light yellow, film-coated, oval shaped tablet.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Low Centyl K is indicated in the management of hypertension alone or
in combination with other antihypertensives.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_Adults:_
Hypertension:
1 tablet daily.
Method of administration
For oral administration.
The tablets should be taken with or after meals with at least a full
glass of water or fluid.
4.3 CONTRAINDICATIONS
Hypersensitivity to the active substances or to any of the excipients
listed in section 6.1.
Addison’s disease.
Severe renal impairment or anuria (see section 4.4)
Severe hepatic impairment (see section 4.4)
Established arthritis urica.
Severe dehydration electrolyte imbalance including hypercalcaemia,
hyponatraemia, hyperchloraemia,
hyperkalaemia or any situation which might lead to hyperkalaemia.
Ulcer or obstruction of the gastrointestinal tract.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Hypersensitivity
Bendroflumethiazide is a sulphonamide, which should be considered by
prescribers in relation to hypersensitivity.
Renal Impairment, Hepatic impairment and Urinary tract obstruction
Thiazide diuretics should be used with caution in patients with mild
or moderate renal or hepatic impairment and in
patients with potential obstruction of the urinary tract (see section
4.3).
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___